IL4 and Alzheimer disease: We demonstrated that manipulation of IL4 switched immune restoration-like phenotypes between survival and non-survival and suggests IL4 agonism may represent a potential immune-restorative target in AD/ACLF patients who develop increased circulatory inflammatory markers during hospitalization.